Jose Cisneros Trigo

E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor Abundance @CeMM_News @georg_e_winter @AlexanderHanzl @fischerlab1 #E3Specific #Degrader #Tracing #Receptor #Abundance pubs.acs.org/doi/10.1021/ja…

Very interesting article in @cenmag on the high potential of lysine-targeting covalent drugs. Great to see the highlight of the exciting contributions by e.g. the groups of @Abbasov_Cornell, Maurizio Pellecchia, Itaru Hamachi and Jack Taunton. cen.acs.org/pharmaceutical…

📢The CeMM Pre-ERC #Postdoc Program Fall Call is now open! Are you eager to pursue groundbreaking biomedical research? Join us & prepare yourself for a successful #ERCStG application & an independent #research career! 🗓️Deadline: 31 July 2021 Apply now➡️cemm.at/postdoc-progra…

Sulfoximines as Rising Stars in Modern Drug Discovery? pubs.acs.org/doi/10.1021/ac…

Joe Biden is the first US President to be sworn in on March’s Advanced Organic Chemistry. #chemtwitter

Our new paper describing the development of a sulfonyl-triazole probe capable of profiling kinase functional sites directly in live cells. @ChemistryUVA @uvavpr @UVA_College @uva_bims @UvaChemPubs pubs.rsc.org/en/content/art…

BenchMarks In this issue of Cell: The Rise of Molecular Glues,The Rise of Molecular Glues zpr.io/HVB92

📢Are you looking for new #JobOpportunities in science? Come join us at @CeMM_News, an international scientific institute with a highly innovative & collaborative atmosphere in Vienna🇦🇹 Take a look at our current vacancies & apply now!➡️cemm.at/career/open-po… #ScienceCareers

We are looking for PhD candidates with a passion for drug discovery to join our young and enthusiastic team @LMUMunich. Our lab is focused on developing new treatments for lung cancer by harnessing medicinal chemistry, cancer cell biology and chemical proteomics. #PhDGermany

Prof Brennan and Saleta have edited an excellent book on the use of chemical probes as part of the @RoySocChem Chemical Biology book series, featuring great contributions from @KawamuraGroup, @london_lab and many others. Available for pre-order here: pubs.rsc.org/en/content/ebo…

#SalivaDirect just received @US_FDA emergency use authorization. The saliva test will help address current testing difficulties like supply chain issues, long wait times, and uncomfortable nasal swabs. @YaleEMD @awyllie13 @NathanGrubaugh @VogelsChantal news.yale.edu/2020/08/15/yal…

A new paper from @georg_e_winter and @CrisMayorRuiz performed chemical profiling in hyponeddylated cells coupled with multi-omics target deconvolution to identify molecular glue degraders of cyclin K. nature.com/articles/s4158…

👇👇Check our latest paper: Rational discovery of molecular glue degraders via scalable chemical profiling @nchembio @georg_e_winter @CeMM_News

Our group has several postdoc positions available in antiviral- and human microbiome-focused drug discovery and design. For those chemists and biochemists interested, please apply and retweet! @scrippsresearch

Please RT: We are hiring! If you're excited about: ✔️force field design ✔️#compchem ✔️code development apply for our 3-year #UKRIFLF funded postdoc position @ChemistryNCL @UniofNewcastle! Deadline: 9th Aug. blogs.ncl.ac.uk/danielcole/con… #chemjobs #ukchemjobs @UKRI_News #QUBEKit

A ver, Tuiter: Buscamos un candidato para Doctorado Industrial. A medias entre una empresa de ingeniería (que ya está esperando) y nuestro @GrupoBIOMIL. Un Proyecto a mitad de camino entre ingeniería, informática, biofisica y biomedicina. Nada menos. Urgente. A ver quien se anima

Something big is coming up @UTM... the future home of the Centre for Medicinal Chemistry! Very excited to watch this new building establish UTM as an international hub for drug discovery research & innovation. #CMC #medchem @UofT @citymississauga utm.utoronto.ca/support-utm/ce…

#ResearchArticle: CH-π-interactions are crucial determinants for the affinity of arguably every drug molecule, but they are often overlooked in #DrugDesign. In @angew_chem, our researchers and @MaxPerutzLabs @univienna show how to measure the interactions: bit.ly/2yD34xw

New release of 216 SARS-CoV-2 genomes in Austria published by @CeMM_News & @oeaw researchers (@Bergthalerlab, Bock’s lab & BSF Facility) in cooperation w/ @MedUni_Wien provides crucial insights into mutational landscape & evolution of #COVID19 in Austria cemm.at/news

Today, Proxygen GmbH, a startup by @CeMM_News, Georg Winter, Giulio Superti-Furga, Stefan Kubicek & Matthias Brand has been founded to develop therapies against cancer by reprogramming the cellular protein quality control system➡️cemm.at/news/ #Proxygen #TechTransfer